AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership10,784 shares
Latest Disclosed Value $ 2,345,512
Intellectus Partners, LLC ownership in ABBV / AbbVie Inc.

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 10,784 shares of AbbVie Inc. (US:ABBV) valued at $2,345,412 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 6,474 shares of AbbVie Inc.. This represents a change in shares of 66.57% during the quarter. The current value of the position is $2,341,530 USD.

Intellectus Partners, LLC has a history of taking positions in derivatives of the underlying security (ABBV) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ABBV / AbbVie Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F ABBVIE COM 00287Y109 10,784 4,310 66.57 2,346 58.55 0.4788
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 6,474 335 5.46 1,479 4.08 0.2858
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 6,139 2 0.03 1,421 24.76 0.2754
2025-08-05 2025-06-30 13F ABBVIE COM 00287Y109 6,137 2 0.03 1,139 -11.36 0.2460
2025-04-11 2025-03-31 13F ABBVIE COM 00287Y109 6,135 9 0.15 1,285 18.11 0.3171
2025-02-07 2024-12-31 13F ABBVIE COM 00287Y109 6,126 -5 -0.08 1,089 -10.08 0.2409
2024-11-06 2024-09-30 13F ABBVIE COM 00287Y109 6,131 -4,408 -41.83 1,211 -33.04 0.3094
2024-07-18 2024-06-30 13F ABBVIE COM 00287Y109 10,539 4,931 87.93 1,808 76.98 0.4933
2024-05-03 2024-03-31 13F ABBVIE COM 00287Y109 5,608 -7,187 -56.17 1,021 -48.49 0.2686
2024-02-05 2023-12-31 13F ABBVIE COM 00287Y109 12,795 -37 -0.29 1,983 3.66 0.5722
2023-10-25 2023-09-30 13F ABBVIE COM 00287Y109 12,832 -13 -0.10 1,913 10.52 0.6051
2023-07-31 2023-06-30 13F ABBVIE COM 00287Y109 12,845 27 0.21 1,731 -15.28 0.5194
2023-05-04 2023-03-31 13F ABBVIE COM 00287Y109 12,818 1,598 14.24 2,043 12.63 0.6450
2023-02-02 2022-12-31 13F Abbvie Inc Com Equity 00287Y109 11,220 58 0.52 1,813 21.03 0.6312
2022-11-14 2022-09-30 13F Abbvie Inc Com Equity 00287Y109 11,162 -346 -3.01 1,498 -15.03 0.5328
2022-08-12 2022-06-30 13F Abbvie Inc Com Common Stock 00287Y109 11,508 -800 -6.50 1,763 -11.63 0.6057
2022-05-16 2022-03-31 13F Abbvie Inc Com Common Stock 00287Y109 12,308 2,845 30.06 1,995 55.74 0.5955
2022-02-14 2021-12-31 13F Abbvie Inc Com Common Stock 00287Y109 9,463 -20 -0.21 1,281 25.22 0.3265
2021-11-16 2021-09-30 13F Abbvie Inc Com Equity 00287Y109 9,483 173 1.86 1,023 -2.48 0.2476
2021-08-13 2021-06-30 13F Abbvie Inc Com Equity 00287Y109 9,310 5,075 119.83 1,049 129.04 0.2365
2021-05-17 2021-03-31 13F Abbvie Inc Com Equity 00287Y109 4,235 -7,994 -65.37 458 -65.04 0.1258
2021-02-18 2020-12-31 13F/A-1 Abbvie Inc Com Common Stock 00287Y109 12,229 -660 -5.12 1,310 16.03 0.3920
2021-02-12 2020-12-31 13F Abbvie Inc Com Common Stock 00287Y109 53 -12,836 1,310 389,501.8836
2020-11-16 2020-09-30 13F Abbvie Inc Com Common Stock 00287Y109 12,889 -1,984 -13.34 1,129 -22.67 0.4266
2020-08-14 2020-06-30 13F Abbvie Inc Com Equity 00287Y109 14,873 14,873 1,460 0.5659
2020-05-13 2020-03-31 13F Abbvie Inc Com Common Stock 00287Y109 0 -12,191 -100.00 0 -100.00
2020-01-24 2019-12-31 13F Abbvie Inc Com Common Stock 00287Y109 12,191 404 3.43 1,079 20.83 0.4390
2019-10-10 2019-09-30 13F Abbvie Inc Com Equity 00287Y109 11,787 2,313 24.41 893 29.61 0.3925
2019-08-08 2019-06-30 13F Abbvie Inc Com Common Stock 00287Y109 9,474 1,200 14.50 689 3.30 0.2981
2019-05-15 2019-03-31 13F Abbvie Inc Com Equity 00287Y109 8,274 1,625 24.44 667 8.81 0.2869
2019-02-14 2018-12-31 13F Abbvie Inc Com COM 00287Y109 6,649 -803 -10.78 613 -13.05 0.4204
2018-11-15 2018-09-30 13F Abbvie Inc Com Equity 00287Y109 7,452 651 9.57 705 11.90 0.2463
2018-08-14 2018-06-30 13F Abbvie Inc Com Equity 00287Y109 6,801 1,175 20.89 630 18.20 0.2298
2018-05-15 2018-03-31 13F Abbvie Inc Com Equity 00287Y109 5,626 4,314 328.81 533 319.69 0.1831
2018-02-13 2017-12-31 13F Abbvie Inc Com Equity 00287Y109 1,312 0 0.00 127 8.55 0.0474
2017-11-14 2017-09-30 13F Abbvie Inc Com Equity 00287Y109 1,312 0 0.00 117 23.16 0.0485
2017-08-15 2017-06-30 13F Abbvie Inc Com Equity 00287Y109 1,312 378 40.47 95 55.74 0.0428
2017-05-08 2017-03-31 13F Abbvie Inc Com Equity 00287Y109 934 0 0.00 61 5.17 0.0310
2017-02-14 2016-12-31 13F Abbvie Inc Com Equity 00287Y109 934 934 58 0.0302
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-08-14 2018-06-30 13F Call ABBV @ $100.0 Exp May 18, 2018 Derivative Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F Call ABBV @ $100.0 Exp May 18, 2018 Derivative Call 600 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.